Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Msci Europe UCITS ETF 1d
LU1242369327 · LU1242369327 · USD · domicile Luxembourg
Equity · EuropeSFDR art. 6 (inferred)
Index tracked: MSCI Total Return Net Europe Index (USD)
- TER
- 0.12%+ trans. 0.01%
- Fund size
- 8.6 bn EUR
- Tracking difference
- +0.30%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Distributingquarterly
Launch 30 Sept 2015 · costs from the KID as of 2 Sept 2026 · 400 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the MSCI Total Return Net Europe Index (index) which is designed to reflect the performance of the listed shares of certain companies from European developed markets.
DESCRIPTION OF INDEX:
The companies making up the index are large and medium sized companies based on the combined value of a company’s readily available shares as compared to other companies. A company’s weighting on the index depends on its relative size.
INDEX…
Performance since series start (in euro) — base 100
30 Sept 2015 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +21.2% |
| 3 years | +54.5% |
| 5 years | +60.7% |
| 10 years | +143.0% |
| Since series start | +153.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 14.85% | 14.92% | 17.52% |
| Max drawdown | −11.40% | −14.17% | −34.06% |
| Sharpe | 0.95 | 0.80 | 0.29 |
| Sortino | 1.46 | 1.16 | 0.41 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU1242369327 · LU12423693271
RebalixLU1242369327 · LU1242369327 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +35.77% | +35.41% | +0.37% |
| 2024 | +2.02% | +1.79% | +0.23% |
| 2023 | +20.18% | +19.89% | +0.29% |
| 2022 | −14.87% | −15.06% | +0.19% |
| 2021 | +16.58% | +16.30% | +0.28% |
Distributions · per share, in USD
Frequency: quarterly · last 12 months: 2.6223 USD (2.46% of NAV) · last ex-date 19 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 2.3211 | — |
| 2025 | 4 | 2.3771 | +3.20% |
| 2024 | 4 | 2.5402 | +3.38% |
| 2023 | 4 | 2.1011 | +3.26% |
| 2022 | 4 | 3.6162 | +4.53% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 2 Sept 2026 · 400 securities · top-10 weight = 21.1%
| Top holdings | Weight |
|---|---|
| 4.5% | |
| 2.5% | |
| 2.1% | |
| 2.1% | |
| 1.8% | |
| 1.7% | |
| 1.7% | |
| 1.6% | |
| 1.5% | |
| 1.5% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
XIEE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 8 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1242369327
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1242369327
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU1242369327 · LU12423693272